NYSE:PBH Prestige Consumer Healthcare (PBH) Stock Price, News & Analysis $46.05 +0.73 (+1.62%) Closing price 11/13/2026 03:59 PM EasternExtended Trading$46.76 +0.71 (+1.54%) As of 11/13/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Prestige Consumer Healthcare Stock (NYSE:PBH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get PBH alerts:Sign Up Key Stats Today's Range$45.23▼$46.4150-Day Range$43.03▼$53.1552-Week Range$41.77▼$71.07Volume500,437 shsAverage Volume637,658 shsMarket Capitalization$2.18 billionP/E Ratio10.12Dividend YieldN/APrice Target$67.00Consensus RatingHold Company Overview Prestige Consumer Healthcare, Inc. develops, markets and distributes over-the-counter health and personal-care products. Its portfolio includes brands such as Dramamine for motion sickness, Clear Eyes for eye care, Chloraseptic for sore-throat relief, Compound W for wart removal, and Summer’s Eve for feminine care. The company’s products serve categories including eye and ear care, cough and cold relief, pain relief, digestive health, and women’s health. They are sold through retail channels such as drugstores, supermarkets, mass-market retailers and online sellers. Prestige Consumer Healthcare serves consumers in North America and select international markets. The company traces its roots to Prestige Brands, which was established in 1996, and adopted its current name in 2018.AI Generated. May Contain Errors. Read More Prestige Consumer Healthcare Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks70th Percentile Overall ScorePBH MarketRank™: 3.478888014685 of 5 starsPrestige Consumer Healthcare scored higher than 70% of companies evaluated by MarketBeat, and ranked 222nd out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingHold Consensus RatingPrestige Consumer Healthcare has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 3 hold ratings, and 1 sell rating.Upside PotentialPrestige Consumer Healthcare has a consensus price target of $67.00, representing about 45.5% upside from its current price of $46.05.Amount of Analyst CoveragePrestige Consumer Healthcare has only been the subject of 3 research reports in the past 90 days.Read more about Prestige Consumer Healthcare's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth12.22% Earnings GrowthEarnings for Prestige Consumer Healthcare are expected to grow by 12.22% in the coming year, from $4.50 to $5.05 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Prestige Consumer Healthcare is 10.12, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.03.Price to Earnings Ratio vs. SectorThe P/E ratio of Prestige Consumer Healthcare is 10.12, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.39.Price to Earnings Growth RatioPrestige Consumer Healthcare has a PEG Ratio of 1.44. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioPrestige Consumer Healthcare has a P/B Ratio of 1.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted9.09% of the float of Prestige Consumer Healthcare has been sold short.Short Interest Ratio / Days to CoverPrestige Consumer Healthcare has a short interest ratio ("days to cover") of 8.05.Change versus previous monthShort interest in Prestige Consumer Healthcare has recently increased by 7.09%, indicating that investor sentiment is decreasing significantly. Dividend0.8 / 5Dividend StrengthN/A Dividend YieldPrestige Consumer Healthcare does not currently pay a dividend.Dividend GrowthPrestige Consumer Healthcare does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Prestige Consumer Healthcare will have a dividend payout ratio of 37.62% next year. This indicates that Prestige Consumer Healthcare will be able to sustain or increase its dividend. News and Social Media2.7 / 5News Sentiment0.35 News SentimentPrestige Consumer Healthcare has a news sentiment score of 0.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Prestige Consumer Healthcare this week, compared to 3 articles on an average week.Search Interest9 people have searched for PBH on MarketBeat in the last 30 days. This is an increase of 13% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Prestige Consumer Healthcare insiders have not sold or bought any company stock.Percentage Held by Insiders1.50% of the stock of Prestige Consumer Healthcare is held by insiders.Percentage Held by Institutions99.95% of the stock of Prestige Consumer Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Prestige Consumer Healthcare's insider trading history. Receive PBH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PBH Stock News HeadlinesPrestige Consumer Healthcare Inc. 2027 Q2 - Results - Earnings Call PresentationNovember 9, 2026 | seekingalpha.comPrestige Consumer Healthcare (NYSE:PBH) Stock Gets Price Target Trim from Canaccord Genuity GroupNovember 9, 2026 | americanbankingnews.comToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th. | Behind the Markets (Ad)Prestige Consumer Healthcare (NYSE:PBH) Reaches New 52-Week Low on Analyst DowngradeNovember 8, 2026 | americanbankingnews.comPrestige Consumer Healthcare Inc. (PBH) Q2 2027 Earnings Call TranscriptNovember 7, 2026 | seekingalpha.comPrestige Consumer Healthcare (PBH) Stock Dropped, So What Is Driving Attention Now?November 6, 2026 | finance.yahoo.comPrestige Consumer Healthcare Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026November 5, 2026 | marketscreener.comMPrestige Healthcare (PBH) Q2 2027 Earnings Call TranscriptNovember 5, 2026 | finance.yahoo.comSee More Headlines PBH Stock Analysis - Frequently Asked Questions How have PBH shares performed this year? Prestige Consumer Healthcare's stock was trading at $61.69 at the start of the year. Since then, PBH shares have decreased by 25.3% and is now trading at $46.0540. How were Prestige Consumer Healthcare's earnings last quarter? Prestige Consumer Healthcare Inc. (NYSE:PBH) posted its quarterly earnings results on Thursday, November, 5th. The company reported $1.13 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.06. The company's revenue for the quarter was up 22.7% on a year-over-year basis. Read the conference call transcript. Who are Prestige Consumer Healthcare's major shareholders? Top institutional investors of Prestige Consumer Healthcare include State Street Corp (4.66%), Allspring Global Investments Holdings LLC (1.97%), Leeward Investments LLC MA (1.11%) and Marshall Wace LLP (0.65%). Insiders that own company stock include Ronald M Lombardi, Jeffrey Zerillo, William P'pool, Adel Mekhail and Mary Beth Fritz. View institutional ownership trends. How do I buy shares of Prestige Consumer Healthcare? Shares of PBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Prestige Consumer Healthcare own? Based on aggregate information from My MarketBeat watchlists, some other companies that Prestige Consumer Healthcare investors own include Boeing (BA), NVIDIA (NVDA), Visa (V), Advanced Micro Devices (AMD), Caterpillar (CAT), Walt Disney (DIS) and GE Aerospace (GE). Company Calendar Last Earnings11/05/2026Today11/13/2026Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (1w+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 For the last 9 days, PBH's financial health has been in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNYSE:PBH CIK1295947 Webwww.prestigebrands.com Phone(914) 524-6800Fax302-674-5266Employees890Year Founded1996Price Target and Rating Average Price Target for Prestige Consumer Healthcare$67.00 High Price Target$70.00 Low Price Target$65.00 Potential Upside/Downside+45.5%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)$3.24 Trailing P/E Ratio10.12 Forward P/E Ratio9.12 P/E Growth1.44Net Income$190.30 million Net Margins13.29% Pretax Margin18.21% Return on Equity11.28% Return on Assets5.25% Debt Debt-to-Equity Ratio1.08 Current Ratio2.92 Quick Ratio1.86 Sales & Book Value Annual Sales$1.09 billion Price / Sales2.01 Cash Flow$5.29 per share Price / Cash Flow8.70 Book Value$41.03 per share Price / Book1.12Miscellaneous Outstanding Shares47,400,000Free Float46,686,000Market Cap$2.18 billion OptionableOptionable Beta0.30 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NYSE:PBH) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | SponsoredExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredMy next big call (under $1)17,556% on KDA. 3,900% on PRE. 2,650% on OCEAN. Every single one of these was recommended to our community bef...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prestige Consumer Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Prestige Consumer Healthcare With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
